BioConsortia Appoints Dr. Damian Curtis as Senior Vice President of Research & Development
Dr. Damian Curtis, Senior Vice President of Research & Development, BioConsortia • Photo Credit: BioConsortia
DAVIS, Calif. — Agricultural biotechnology company BioConsortia has appointed Dr. Damian Curtis as Senior Vice President of Research & Development as the company expands its microbial genomics and agricultural innovation platform.
Dr. Curtis succeeds Dr. Hong Zhu, who transitions to BioConsortia’s Strategic Advisory Board, where he will continue supporting the company’s long-term scientific strategy.
Curtis will oversee research and development initiatives focused on microbial genomics, gene editing, strain optimization, and biological crop solutions designed to improve productivity and sustainability outcomes across global agriculture markets.
“Damian’s appointment reflects the exceptional caliber of scientific talent we have built at BioConsortia. Promoting from within demonstrates the strength of our R&D organization and our confidence in the scientific foundation that has made us a leader in agricultural microbial innovation. Damian combines deep expertise in microbiology, genomics, and gene editing with the strategic vision to translate cutting-edge science into commercially impactful agricultural products,” said Marcus Meadows-Smith, Chief Executive Officer of BioConsortia.
Curtis brings nearly two decades of leadership experience spanning agricultural biology and biopharmaceutical research. He previously worked at Bayer, Exelixis, and AgraQuest, where he focused on microbial biology, genomics, agricultural applications, and biological crop protection technologies.
Since joining BioConsortia, Curtis has contributed to the advancement of the company’s microbial discovery platform and genome-informed strain development capabilities.
“BioConsortia has assembled one of the most advanced microbial R&D organizations in agriculture. What differentiates this company is the integration of discovery biology, genomics, computational analytics, strain engineering, fermentation, formulation, and field development into a single innovation engine. I’m excited to expand our capabilities in microbial genomics and gene editing to develop next-generation biological solutions that deliver meaningful value to growers globally,” said Curtis.
Curtis’s appointment comes as BioConsortia advances seed treatment technologies targeting nitrogen efficiency, crop productivity, and sustainable agricultural outcomes.
During his tenure as Senior Vice President of Research & Development, Zhu helped expand BioConsortia’s scientific and product development capabilities across microbial discovery and translational science initiatives.
“Hong’s leadership established the company’s reputation for technical excellence and positioned us for our next chapter of growth. We are pleased that he will continue contributing as a strategic advisor,” said Meadows-Smith.
BioConsortia develops microbial technologies for agriculture, including nitrogen-fixing, biocontrol, and biostimulant products designed to reduce dependence on synthetic agricultural inputs.
Source: BioConsortia | www.bioconsortia.com